6505--Esomeprazole Magnesium Capsules Effective 10/19/2026 - 10/18/2027
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79726R0027
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
This procurement notice announces the award of a contract for the supply of Esomeprazole Magnesium Capsules, with an effective period from October 19, 2026, through October 18, 2027. The contract is managed by the National Acquisition Center (NAC) Pharmaceuticals division, operating under the Department of Veterans Affairs (VA). The primary objective of this procurement is to ensure a reliable and consistent supply of Esomeprazole Magnesium Capsules, a pharmaceutical product classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), to support the healthcare needs of veterans served by the VA.
The scope of this contract encompasses the manufacturing and delivery of Esomeprazole Magnesium Capsules in accordance with federal pharmaceutical standards and VA-specific requirements. The intended outcome is to maintain uninterrupted access to this essential medication, which is widely used for the treatment of gastrointestinal conditions, thereby supporting the VA’s mission to provide high-quality healthcare to veterans.
Key requirements for this procurement include adherence to all applicable regulatory standards for pharmaceutical manufacturing, quality assurance, and timely delivery schedules as specified by the VA. Contractors are expected to demonstrate robust capabilities in pharmaceutical preparation, including compliance with current Good Manufacturing Practices (cGMP) and the ability to meet the VA’s volume and quality demands throughout the contract period.
The contracting entity for this award is the NAC Pharmaceuticals office (organization key: 500000036), a federal office within the Department of Veterans Affairs. The primary point of contact for this procurement is James Sullivan, who can be reached via email at [email protected] or by phone at (708) 786-5239. The notice is currently active and was posted on August 19, 2026.
This procurement is classified under Product Service Code 6505, which pertains to drugs and biologicals. The opportunity was sourced through the federal government’s official procurement platform, SAM.gov, and further details, including any attachments, can be accessed via the provided notice URL.
Contractors considering this opportunity should note that it is an award notice, indicating that the contract has already been awarded. The notice does not specify any set-aside requirements or special considerations such as small business preferences. The primary focus remains on the consistent supply and quality of Esomeprazole Magnesium Capsules for the VA healthcare system.
In summary, this contract represents a critical component of the VA’s pharmaceutical supply chain, ensuring that veterans continue to receive necessary medications without interruption. Contractors with expertise in pharmaceutical manufacturing and a proven track record of meeting federal healthcare requirements would find this type of opportunity well-aligned with their capabilities.